The limitations of observation studies for decision making regarding drugs efficacy and safety
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical)
Reference31 articles.
1. Why did the randomized clinical trial become the primary focus of my career?;Sackett;Value Health,2015
2. Restoring sutdy 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence;Le Noury;BMJ,2015
3. Sick population – treated population: the need for a better definition. The VALIDATA Group;Collet;Eur J Clin Pharmacol,1991
4. Causation in epidemiology. Basic epidemiology;Beaglehole,1993
5. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD;Criner;N Engl J Med,2014
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Harnessing customized AI to create voice of customer via GPT3.5;Advanced Engineering Informatics;2024-08
2. Plasma proteins and inflammatory dermatoses: proteome-wide Mendelian randomization and colocalization analyses;Archives of Dermatological Research;2024-07-01
3. Insulin Degludec in People with Type 2 Diabetes in China: A Non-interventional, Retrospective Chart Review Study (CN-TREAT);Diabetes Therapy;2024-03
4. A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting;The American Journal on Addictions;2024-01-30
5. The potential impact of policies and structural interventions in reducing cardiovascular disease and mortality: a systematic review of simulation-based studies;Health Technology Assessment;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3